Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Bevacizumab Pretreatment and Long Acting Gas Infusion on the Vitreous Clear-up After Diabetic Vitrectomy

NCT00656435 is registered in ClinicalTrials.gov with National Taiwan University Hospital as lead sponsor.

NCT NCT00656435
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00656435 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Bevacizumab Pretreatment and Long Acting Gas Infusion on the Vitreous Clear-up After Diabetic Vitrectomy
Lead sponsor
National Taiwan University Hospital
Phase
Phase 3
Overall status
Completed
Start date
December 31, 2006
Completion date
February 29, 2008
Enrollment
16 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

proliferative diabetic retinopathy